1Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA;
2AMPATH, Moi University, Eldoret, Kenya;
3University of KwaZulu-Natal, Durban, South Africa;
4Virginia Commonwealth University School of Medicine;
5Infectious Disease Institute, Kampala, Uganda;
6Indiana University, Indianapolis, IN, USA;
7University of California San Francisco, CA, USA;
8University of Connecticut, Storrs, CT, USA
Corresponding Author: Esther Freeman, MD, PhD Massachusetts General Hospital Department of Dermatology 50 Staniford St, Boston, MA 02114 Email: [email protected] Phone: 617-726-2914
Conflicts of Interest: The authors declare no potential conflicts of interest.
*Co-first authors
Funding: Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases (NIAID) under Award Numbers U01AI069911 (East Africa IeDEA Consortium), K23AI136579, and K24AI141036 and by the National Cancer Institute (NCI) under Award Number U54CA190153 and U54CA254571. Dr. Freeman also received support from a Dermatology Foundation Career Development Award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Dermatology Foundation.
